The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Stocks•8 May 2026•

1 min read

A2Z Cust2Mate and PAVmed Unlikely to Beat Earnings Estimates Next Week

Key Facts

1A2Z Cust2Mate Solutions Corp. (AZ) is expected to lack the key ingredients for a likely earnings beat in its upcoming report.

2PAVmed Inc. (PAVM) does not possess the combination of factors typically associated with an earnings beat for its next report.

Zacks Investment Research indicates that both A2Z Cust2Mate Solutions Corp. and PAVmed Inc. are unlikely to surprise the market with positive earnings beats in their upcoming financial disclosures. According to the firm's proprietary methodology, neither company possesses the specific combination of Earnings ESP and Zacks Rank typically associated with an earnings beat. For A2Z Cust2Mate (AZ), the quantitative model suggests a lack of momentum heading into the report scheduled for next week. Similarly, PAVmed Inc. (PAVM) is expected to face headwinds that may prevent it from exceeding analyst consensus estimates. This assessment provides a cautious outlook for investors monitoring these small-cap stocks. Market participants will be closely watching the official releases to see if these quantitative predictions align with actual fiscal performance.